Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Hypericin
Potential treatment - theoretical effect Natural product Antiviral Mar/08/2021
Aptamer-2
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
Aptamer-1
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
Famotidine
Potential treatment - clinical evidence Used to treat other disease Unknown Mar/08/2021
6-beta-D-Glucopyranosyl-4',5-dihydroxy-7-methoxyflavone
Potential treatment - theoretical effect Natural product Antiviral Mar/08/2021
COVA1-16
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
mAb 2-36
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
mAb 2-7
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
mAb 2-15
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
C135
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
Indinavir
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/07/2021
Teicoplanin
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/06/2021
Bromelain
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/06/2021
N-acetylcysteine
Potential treatment - pre-clinical evidence Used to treat other disease Other treatment Mar/06/2021
Menstrual blood-derived stem cells
Potential treatment - clinical evidence Experimental Other treatment Mar/06/2021
Hydroxyitraconazole
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/05/2021
Bis4
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/05/2021
Bis3
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/05/2021
N-[(7S)-1,2,10-Trimethoxy-9-oxo-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
Potential treatment - theoretical effect Experimental Antiviral Mar/05/2021
N-3-{[(7S)-7-(acetylamino)-1,2,3-trimethoxy-11-(4-methoxyphenyl)-9-oxo-5,6,7,9-tetrahydrobenzo[9,10]heptaleno[3,2-b]furan-12-yl]acetyl}-N-[(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)methyl]-beta-alaninamide
Potential treatment - theoretical effect Experimental Antiviral Mar/05/2021